NeuroVive Pharmaceutical AB Piaci kupak
Mi az NeuroVive Pharmaceutical AB Piaci kupak?
A Piaci kupak az NeuroVive Pharmaceutical AB - $15.23M
Mi a Piaci kupak meghatározása?
A piaci kapitalizáció a tőzsdén jegyzett társaság részvényeinek egy adott időpontban érvényes piaci értéke, amely megegyezik a fennálló részvények számának azon időpontjában érvényes részvényárral .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Piaci kupak a Miscellaneous szektor a LSE-on cégekben a NeuroVive Pharmaceutical AB -hoz képest
Mit csinál NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
piaci kupak -hoz hasonló cégek NeuroVive Pharmaceutical AB
- TV2U International nak Piaci kupak $15.21M van
- GSE Systems nak Piaci kupak $15.21M van
- GSE Systems nak Piaci kupak $15.21M van
- P2 Gold nak Piaci kupak $15.22M van
- Orosur Mining nak Piaci kupak $15.23M van
- Maritime Resources nak Piaci kupak $15.23M van
- NeuroVive Pharmaceutical AB nak Piaci kupak $15.23M van
- Pro Fin Capital Services nak Piaci kupak $15.24M van
- Pivotal Systems nak Piaci kupak $15.25M van
- Hemogenyx Pharmaceuticals Plc nak Piaci kupak $15.25M van
- Gunpoint Exploration nak Piaci kupak $15.26M van
- Silk Road Services nak Piaci kupak $15.27M van
- Nvoi nak Piaci kupak $15.28M van